Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chee M Ng

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 4, 2013
Modeling approach to investigate the effect of neonatal Fc receptor binding affinity and anti-therapeutic antibody on the pharmacokinetic of humanized monoclonal anti-tumor necrosis factor-α IgG antibody in cynomolgus monkeyChee M Ng, Kelly M Loyet, Suhasini Iyer, et al.
Pharmaceutical Research|November 26, 2005
Pharmacokinetics/pharmacodynamics of nondepleting anti-CD4 monoclonal antibody (TRX1) in healthy human volunteersChee M Ng, Eric Stefanich, Banmeet S Anand, et al.
Cancer Chemotherapy and Pharmacology|July 9, 2010
Mechanism-based pharmacokinetic/pharmacodynamic model for troxacitabine-induced neutropenia in cancer patientsChee M Ng, A Patnaik, M Beeram, et al.
Cancer Chemotherapy and Pharmacology|May 27, 2009
Mechanism-based receptor-binding model to describe the pharmacokinetic and pharmacodynamic of an anti-α5β1 integrin monoclonal antibody (volociximab) in cancer patientsChee M Ng, S Bai, C H Takimoto, et al.
Pharmaceutical Research|July 20, 2005
Pharmacokinetic-pharmacodynamic-efficacy analysis of efalizumab in patients with moderate to severe psoriasisChee M Ng, Amita Joshi, Russell L Dedrick, et al.
British Journal of Clinical Pharmacology|October 28, 2017
Population pharmacokinetics of exendin-(9-39) and clinical dose selection in patients with congenital hyperinsulinismChee M Ng, Fei Tang, Steven H Seeholzer, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|May 7, 2014
Population pharmacokinetics of unbound hydrocortisone in critically ill neonates and infants with vasopressor-resistant hypotensionHeather E Vezina, Chee M Ng, Delia M Vazquez, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|December 21, 2012
Population pharmacokinetics of phenobarbital in infants with neonatal encephalopathy treated with therapeutic hypothermiaRenée A Shellhaas, Chee M Ng, Christina H Dillon, et al.
Cancer Chemotherapy and Pharmacology|October 12, 2012
PK-PD modeling of combination efficacy effect from administration of the MEK inhibitor GDC-0973 and PI3K inhibitor GDC-0941 in A2058 xenograftsEdna F Choo, Chee M Ng, Leanne Berry, et al.
Pharmacotherapy|July 15, 2015
Population Pharmacokinetic Model of Sublingual Buprenorphine in Neonatal Abstinence SyndromeChee M Ng, Erin Dombrowsky, Hopi Lin, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 4, 2013
Modeling approach to investigate the effect of neonatal Fc receptor binding affinity and anti-therapeutic antibody on the pharmacokinetic of humanized monoclonal anti-tumor necrosis factor-α IgG antibody in cynomolgus monkeyChee M Ng, Kelly M Loyet, Suhasini Iyer, et al.
Pharmaceutical Research|November 26, 2005
Pharmacokinetics/pharmacodynamics of nondepleting anti-CD4 monoclonal antibody (TRX1) in healthy human volunteersChee M Ng, Eric Stefanich, Banmeet S Anand, et al.
Cancer Chemotherapy and Pharmacology|July 9, 2010
Mechanism-based pharmacokinetic/pharmacodynamic model for troxacitabine-induced neutropenia in cancer patientsChee M Ng, A Patnaik, M Beeram, et al.
Cancer Chemotherapy and Pharmacology|May 27, 2009
Mechanism-based receptor-binding model to describe the pharmacokinetic and pharmacodynamic of an anti-α5β1 integrin monoclonal antibody (volociximab) in cancer patientsChee M Ng, S Bai, C H Takimoto, et al.
Pharmaceutical Research|July 20, 2005
Pharmacokinetic-pharmacodynamic-efficacy analysis of efalizumab in patients with moderate to severe psoriasisChee M Ng, Amita Joshi, Russell L Dedrick, et al.
British Journal of Clinical Pharmacology|October 28, 2017
Population pharmacokinetics of exendin-(9-39) and clinical dose selection in patients with congenital hyperinsulinismChee M Ng, Fei Tang, Steven H Seeholzer, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|May 7, 2014
Population pharmacokinetics of unbound hydrocortisone in critically ill neonates and infants with vasopressor-resistant hypotensionHeather E Vezina, Chee M Ng, Delia M Vazquez, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|December 21, 2012
Population pharmacokinetics of phenobarbital in infants with neonatal encephalopathy treated with therapeutic hypothermiaRenée A Shellhaas, Chee M Ng, Christina H Dillon, et al.
Cancer Chemotherapy and Pharmacology|October 12, 2012
PK-PD modeling of combination efficacy effect from administration of the MEK inhibitor GDC-0973 and PI3K inhibitor GDC-0941 in A2058 xenograftsEdna F Choo, Chee M Ng, Leanne Berry, et al.
Pharmacotherapy|July 15, 2015
Population Pharmacokinetic Model of Sublingual Buprenorphine in Neonatal Abstinence SyndromeChee M Ng, Erin Dombrowsky, Hopi Lin, et al.
Pageof 4